News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
823,911 Results
Type
Article (74938)
Company Profile (646)
Press Release (748326)
Multimedia
Podcasts (141)
Webinars (19)
Section
Business (227681)
Career Advice (3728)
Deals (39361)
Drug Delivery (129)
Drug Development (89506)
Employer Resources (198)
FDA (17958)
Job Trends (17169)
News (388303)
Policy (38871)
Tag
Academia (3001)
Academic (1)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56148)
ALS (120)
Alzheimer's disease (1571)
Antibody-drug conjugate (ADC) (188)
Approvals (17909)
Artificial intelligence (370)
Autoimmune disease (36)
Automation (19)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (440)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (390)
Cancer (3090)
Cardiovascular disease (249)
Career advice (3179)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (566)
Cervical cancer (24)
Clinical research (73137)
Collaboration (1114)
Company closure (3)
Compensation (715)
Complete response letters (34)
COVID-19 (2904)
CRISPR (68)
C-suite (359)
Cystic fibrosis (122)
Data (3100)
Decentralized trials (2)
Denatured (48)
Depression (76)
Diabetes (378)
Diagnostics (6975)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (157)
Drug pricing (151)
Drug shortages (36)
Duchenne muscular dystrophy (138)
Earnings (94781)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (130357)
Executive appointments (910)
FDA (19703)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1009)
Gene editing (149)
Generative AI (32)
Gene therapy (436)
GLP-1 (935)
Government (5213)
Grass and pollen (6)
Guidances (182)
Healthcare (20898)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (184)
Immuno-oncology (11)
Indications (40)
Infectious disease (3100)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (70)
Intellectual property (125)
Interviews (728)
IPO (17835)
IRA (55)
Job creations (4997)
Job search strategy (2596)
Kidney cancer (14)
Labor market (57)
Layoffs (590)
Leadership (27)
Legal (9940)
Liver cancer (85)
Longevity (12)
Lung cancer (434)
Lymphoma (216)
Machine learning (11)
Management (65)
Manufacturing (440)
MASH (100)
Medical device (14714)
Medtech (14719)
Mergers & acquisitions (22256)
Metabolic disorders (966)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (143)
Neuropsychiatric disorders (42)
Neuroscience (2325)
NextGen: Class of 2025 (7640)
Non-profit (5088)
Now hiring (49)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (122)
Pancreatic cancer (126)
Parkinson's disease (199)
Partnered (23)
Patents (323)
Patient recruitment (174)
Peanut (55)
People (64512)
Pharmaceutical (133)
Pharmacy benefit managers (25)
Phase I (22611)
Phase II (31899)
Phase III (24035)
Pipeline (1709)
Policy (243)
Postmarket research (3258)
Preclinical (9990)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (278)
Rare diseases (528)
Real estate (7164)
Recruiting (76)
Regulatory (26480)
Reports (61)
Research institute (2662)
Resumes & cover letters (580)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (173)
Series B (118)
Service/supplier (27)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (37)
Startups (4213)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (91)
Vaccines (916)
Venture capital (58)
Weight loss (332)
Women's health (50)
Worklife (20)
Date
Today (81)
Last 7 days (375)
Last 30 days (1979)
Last 365 days (33430)
2025 (18170)
2024 (37898)
2023 (42567)
2022 (53926)
2021 (58723)
2020 (57663)
2019 (51302)
2018 (39084)
2017 (36837)
2016 (37746)
2015 (43738)
2014 (38423)
2013 (34408)
2012 (36309)
2011 (36431)
2010 (35861)
Location
Africa (1194)
Alabama (70)
Alaska (7)
Arizona (260)
Arkansas (14)
Asia (49220)
Australia (8416)
California (7803)
Canada (2420)
China (727)
Colorado (340)
Connecticut (347)
Delaware (203)
Europe (110903)
Florida (1160)
Georgia (264)
Hawaii (2)
Idaho (65)
Illinois (725)
India (32)
Indiana (385)
Iowa (19)
Japan (239)
Kansas (115)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1107)
Massachusetts (5962)
Michigan (273)
Minnesota (485)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (72)
New Jersey (2193)
New Mexico (31)
New York (2188)
North Carolina (1242)
North Dakota (10)
Northern California (3366)
Ohio (253)
Oklahoma (17)
Oregon (46)
Pennsylvania (1663)
Puerto Rico (18)
Rhode Island (39)
South America (1568)
South Carolina (36)
South Dakota (1)
Southern California (2894)
Tennessee (129)
Texas (1188)
United States (29391)
Utah (231)
Virginia (213)
Washington D.C. (80)
Washington State (687)
West Virginia (4)
Wisconsin (84)
823,911 Results for "chugai pharmaceutical co ltd japan".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in aging-related diseases. Chugai will then develop antibody-based drugs based on the findings.
July 7, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
JCR Pharmaceuticals Selected for Japan’s Regenerative Medicine CDMO Subsidy Program
July 17, 2025
·
4 min read
Press Releases
Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
July 8, 2025
·
3 min read
Press Releases
Rani Therapeutics Announces Research Agreement with Chugai
May 19, 2025
·
4 min read
Press Releases
Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
June 23, 2025
·
10 min read
Press Releases
Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
June 23, 2025
·
10 min read
Press Releases
Univar Solutions and Shandong Head Group Co., Ltd. Establish Exclusive European Partnership to Enhance Supply of Cellulose Ethers and Pharmaceutical Excipients
May 22, 2025
·
7 min read
Press Releases
Avata Biosciences Signs Co-Development and Licensing Agreement with Oceanus Bio for Exclusive Rights in Japan and Asia (Excluding China and India) for Novel Adult and Pediatric Oral Cannabidiol Therapies for Development in Epilepsy and Schizophrenia
June 17, 2025
·
3 min read
Press Releases
Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris’ AraLinQ™ technology
January 8, 2025
·
2 min read
Press Releases
KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
April 8, 2025
·
4 min read
1 of 82,392
Next
